Skip to main content
letter
. 2022 Aug 3;15(8):100671. doi: 10.1016/j.waojou.2022.100671

Table 1.

Clinical characteristics of 4 clusters of children with atopic dermatitis (AD) and comparison between clusters.

A (Intrinsic) B (Egg white only) C (Multiple foods) D (Inhalants) P value (Cluster comparison)
Subject number, n (%) 71 (27.5%) 28 (10.8%) 68 (26.4%) 91 (35.3%)
Sex ratio (M:F) 1.22:1 (39/32) 2.11:1 (19/9) 1.27:1 (38/30) 1.02:1 (46/45) 0.454
Age at enrollment (years), mean (± standard deviation) 3.3 (±3.4) 1.4 (±1.1).633
0322+6
2.3 (±1.7) 6.3 (±3.9) <0.001
Age at AD onset, n (%) <0.001
 <3 months 25 (35.2%) 13 (46.4%) 21 (30.9%) 20 (22.0%)
 3–6 months 22 (31.0%) 11 (39.3%) 21 (30.9%) 20 (22.0%)
 6–12 months 5 (7.0%) 2 (7.1%) 15 (22.1%) 11 (12.1%)
 >12 months 19 (26.8%) 2 (7.1%) 11 (16.2%) 40 (44.0%)
1st relative family history of allergic diseases, n (%) 46 (64.8%) 24 (85.7%) 47 (69.1%) 64 (70.3%) 0.236
Allergic comorbidities
 Asthma 4 (5.6%) 1 (3.6%) 1 (1.5%) 14 (15.4%) 0.006
 Allergic rhinitis 12 (16.9%) 4 (14.3%) 17 (25.0%) 39 (42.9%) <0.001
 Allergic conjunctivitis 7 (9.9%) 2 (7.1%) 5 (7.4%) 22 (24.2%) 0.006
 Chronic urticaria 5 (7.0%) 0 (0.0%) 4 (5.9%) 5 (5.5%) 0.907
 Food allergy 13 (18.3%) 17 (60.7%) 49 (72.1%) 51 (56.0%) <0.001
Health-related quality of life (0–30), median (range) 5.0 (0–20) 5.0 (0–24) 5.5 (0–23) 8.0 (0–25) 0.028
Total IgE (IU/ml), mean (± standard deviation) 213.2 (±627.7) 87.8 (±114.9) 763.0 (±1368.2) 694.7 (±891.2) 0.006
Previous treatment with systemic immunosuppressants 7 (9.9%) 0 (0.0%) 4 (5.9%) 13 (14.3%) 0.201
Skin infection in the last 1 year 8 (11.3%) 3 (10.7%) 14 (20.6%) 19 (20.9%) 0.260